Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Audio-based therapy to help anxiety in people with psoriasis

Official title: The Effects of Audio-Based Therapy on Anxiety in Psoriasis

Run by University of California, San Francisco · NCT07390487 · Data updated 2026-11-12

This study tests whether a short audio therapy session can ease anxiety in adults with psoriasis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (San Francisco, California)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedJuly 23, 2026
Trial IDNCT07390487 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with self-reported dermatologist-diagnosed psoriasis and at least mild anxiety (GAD-2 score ≥1) who have internet access and can use a computer or smartphone with headphones for a single at-home session.

Probably not a fit

People with severe hearing impairment, certain conditions requiring sound avoidance, or other factors the investigator believes would interfere with participation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will evaluate the effect of audio-based therapy, including music therapy and pink noise, on anxiety symptoms in adults with dermatologist-confirmed psoriasis. Participants will complete a single 23- to 30-minute at-home session using headphones and an internet-enabled device, with pre- and post-intervention surveys to measure changes in anxiety and overall symptoms. The study aims to determine if this accessible intervention can reduce anxiety and potentially improve quality of life for psoriatic patients. The UCSF Liao Lab will conduct the study at its San Francisco location, led by UCSF researchers with no additional collaborators listed.

Why it matters

Potential benefit: If successful, participants may experience reduced anxiety and improved well-being related to psoriasis.

How similar studies have gone: Previous randomized studies have shown anxiety reductions with audio-based therapies, suggesting potential benefit for this approach in psoriatic patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Self-reported dermatologist-diagnosed psoriasis
* GAD 2-Item Score ≥1 at screening
* Ability to consent and complete pre- and post-intervention surveys.
* Internet access and the ability to use a computer/smartphone with headphones for a single 23-30 minute session at home.

Exclusion Criteria:

* Severe hearing impairment precluding headphone listening
* Any condition requiring strict sound avoidance (such as seizure/epilepsy, major head trauma, severe sound-triggered migraine) that would make participation unsafe.
* Other diagnoses that in the investigator's judgment preclude safe participation or interfere with anxiety or psoriasis evaluation.

Where it's running

  • Liao Lab at UCSF
    San Francisco, California, United States
    Recruiting

Study contacts

  • Principal investigator: Wilson Liao, MD — University of California, San Francisco
  • Study coordinator: Amélie Spangenberg, Psoriasis Clinical Research Fellow, MBBS
  • Email: amelie.spangenberg@ucsf.edu
  • Phone: 415-944-7618

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.